Soleno Therapeutics Inc. (SLNO) stock rises during current market. Here’s to know why?
Soleno Therapeutics Inc. (NASDAQ: SLNO) stock gains by 42.65% in the current market, at last check. Soleno focuses on the research and marketing of new treatments for rare illnesses. DCCR Extended-Release pills, a once-daily oral tablet developed by the business, is now being tested in Phase 3 clinical research program for the treatment of Prader-Willi […]